vs
ESPEY MFG & ELECTRONICS CORP（ESP）与Varex Imaging Corp（VREX）财务数据对比。点击上方公司名可切换其他公司
Varex Imaging Corp的季度营收约是ESPEY MFG & ELECTRONICS CORP的17.3倍（$209.6M vs $12.1M）。ESPEY MFG & ELECTRONICS CORP净利率更高（23.1% vs 1.1%，领先22.0%）。Varex Imaging Corp同比增速更快（4.9% vs -10.8%）。ESPEY MFG & ELECTRONICS CORP自由现金流更多（$-4.1M vs $-26.8M）。过去两年ESPEY MFG & ELECTRONICS CORP的营收复合增速更高（21.3% vs 0.8%）
Espey制造电子公司是总部位于美国的制造商，专注于高可靠性电源、电力转换系统及专用电子元件的设计生产，面向航空航天、国防、工业及交通领域，为北美及部分国际市场客户提供适配恶劣运行环境的定制化解决方案。
Varex Imaging是全球知名的影像组件及解决方案供应商，核心产品涵盖X射线管、数字平板探测器和图像处理软件，广泛应用于医疗诊断、放射肿瘤治疗及工业无损检测等领域，客户覆盖全球主要市场。
ESP vs VREX — 直观对比
营收规模更大
VREX
是对方的17.3倍
$12.1M
营收增速更快
VREX
高出15.7%
-10.8%
净利率更高
ESP
高出22.0%
1.1%
自由现金流更多
ESP
多$22.7M
$-26.8M
两年增速更快
ESP
近两年复合增速
0.8%
损益表 — Q2 2026 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $12.1M | $209.6M |
| 净利润 | $2.8M | $2.3M |
| 毛利率 | 34.7% | 33.3% |
| 营业利润率 | 25.3% | 7.3% |
| 净利率 | 23.1% | 1.1% |
| 营收同比 | -10.8% | 4.9% |
| 净利润同比 | 47.0% | 866.7% |
| 每股收益（稀释后） | $0.99 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPVREX
| Q1 26 | — | $209.6M | ||
| Q4 25 | $12.1M | $228.9M | ||
| Q3 25 | $9.1M | $203.0M | ||
| Q2 25 | $9.6M | $212.9M | ||
| Q1 25 | $10.3M | $199.8M | ||
| Q4 24 | $13.6M | — | ||
| Q3 24 | $10.4M | $205.7M | ||
| Q2 24 | $11.6M | $209.1M |
净利润ESPVREX
| Q1 26 | — | $2.3M | ||
| Q4 25 | $2.8M | $12.2M | ||
| Q3 25 | $2.2M | $-89.1M | ||
| Q2 25 | $2.9M | $6.9M | ||
| Q1 25 | $1.7M | $-300.0K | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $1.6M | $-51.1M | ||
| Q2 24 | $1.9M | $1.4M |
毛利率ESPVREX
| Q1 26 | — | 33.3% | ||
| Q4 25 | 34.7% | 34.0% | ||
| Q3 25 | 35.4% | 33.3% | ||
| Q2 25 | 39.3% | 36.0% | ||
| Q1 25 | 28.6% | 34.3% | ||
| Q4 24 | 23.2% | — | ||
| Q3 24 | 26.8% | 32.6% | ||
| Q2 24 | 27.6% | 32.0% |
营业利润率ESPVREX
| Q1 26 | — | 7.3% | ||
| Q4 25 | 25.3% | 8.6% | ||
| Q3 25 | 22.7% | -39.8% | ||
| Q2 25 | 27.4% | 10.4% | ||
| Q1 25 | 17.0% | 5.6% | ||
| Q4 24 | 14.9% | — | ||
| Q3 24 | 16.5% | 5.3% | ||
| Q2 24 | 18.4% | 4.4% |
净利率ESPVREX
| Q1 26 | — | 1.1% | ||
| Q4 25 | 23.1% | 5.3% | ||
| Q3 25 | 23.9% | -43.9% | ||
| Q2 25 | 30.6% | 3.2% | ||
| Q1 25 | 16.5% | -0.2% | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 15.3% | -24.8% | ||
| Q2 24 | 16.3% | 0.7% |
每股收益（稀释后）ESPVREX
| Q1 26 | — | $0.05 | ||
| Q4 25 | $0.99 | $0.29 | ||
| Q3 25 | $0.76 | $-2.15 | ||
| Q2 25 | $1.07 | $0.17 | ||
| Q1 25 | $0.63 | $-0.01 | ||
| Q4 24 | $0.71 | — | ||
| Q3 24 | $0.61 | $-1.25 | ||
| Q2 24 | $0.73 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $17.8M | $125.6M |
| 总债务越低越好 | — | $367.6M |
| 股东权益账面价值 | $53.2M | $476.9M |
| 总资产 | $85.2M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.77× |
8季度趋势，按日历期对齐
现金及短期投资ESPVREX
| Q1 26 | — | $125.6M | ||
| Q4 25 | $17.8M | $155.1M | ||
| Q3 25 | $22.2M | $152.6M | ||
| Q2 25 | $18.9M | $223.0M | ||
| Q1 25 | $13.9M | $212.6M | ||
| Q4 24 | $8.0M | — | ||
| Q3 24 | $4.8M | $200.5M | ||
| Q2 24 | $4.4M | $190.0M |
总债务ESPVREX
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
股东权益ESPVREX
| Q1 26 | — | $476.9M | ||
| Q4 25 | $53.2M | $472.6M | ||
| Q3 25 | $51.0M | $455.3M | ||
| Q2 25 | $50.8M | $549.7M | ||
| Q1 25 | $46.3M | $540.2M | ||
| Q4 24 | $44.8M | — | ||
| Q3 24 | $42.5M | $529.1M | ||
| Q2 24 | $41.3M | $581.2M |
总资产ESPVREX
| Q1 26 | — | $1.1B | ||
| Q4 25 | $85.2M | $1.1B | ||
| Q3 25 | $84.8M | $1.1B | ||
| Q2 25 | $79.1M | $1.4B | ||
| Q1 25 | $72.8M | $1.3B | ||
| Q4 24 | $60.2M | — | ||
| Q3 24 | $57.6M | $1.2B | ||
| Q2 24 | $56.5M | $1.3B |
负债/权益比ESPVREX
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.8M | $-16.1M |
| 自由现金流经营现金流 - 资本支出 | $-4.1M | $-26.8M |
| 自由现金流率自由现金流/营收 | -34.1% | -12.8% |
| 资本支出强度资本支出/营收 | 10.9% | 5.1% |
| 现金转化率经营现金流/净利润 | -1.00× | -7.00× |
| 过去12个月自由现金流最近4个季度 | $11.7M | $-13.3M |
8季度趋势，按日历期对齐
经营现金流ESPVREX
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $-2.8M | $7.9M | ||
| Q3 25 | $5.7M | $7.7M | ||
| Q2 25 | $2.8M | $16.6M | ||
| Q1 25 | $11.5M | $9.5M | ||
| Q4 24 | $5.4M | — | ||
| Q3 24 | $1.4M | $25.9M | ||
| Q2 24 | $3.2M | $8.0M |
自由现金流ESPVREX
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $-4.1M | $2.3M | ||
| Q3 25 | $4.4M | $1.4M | ||
| Q2 25 | $915.3K | $9.8M | ||
| Q1 25 | $10.5M | $5.3M | ||
| Q4 24 | $4.5M | — | ||
| Q3 24 | $724.8K | $19.9M | ||
| Q2 24 | $2.6M | $3.3M |
自由现金流率ESPVREX
| Q1 26 | — | -12.8% | ||
| Q4 25 | -34.1% | 1.0% | ||
| Q3 25 | 48.7% | 0.7% | ||
| Q2 25 | 9.5% | 4.6% | ||
| Q1 25 | 101.8% | 2.7% | ||
| Q4 24 | 33.0% | — | ||
| Q3 24 | 6.9% | 9.7% | ||
| Q2 24 | 22.2% | 1.6% |
资本支出强度ESPVREX
| Q1 26 | — | 5.1% | ||
| Q4 25 | 10.9% | 2.4% | ||
| Q3 25 | 14.2% | 3.1% | ||
| Q2 25 | 19.3% | 3.2% | ||
| Q1 25 | 9.3% | 2.1% | ||
| Q4 24 | 6.5% | — | ||
| Q3 24 | 6.4% | 2.9% | ||
| Q2 24 | 5.7% | 2.2% |
现金转化率ESPVREX
| Q1 26 | — | -7.00× | ||
| Q4 25 | -1.00× | 0.65× | ||
| Q3 25 | 2.64× | — | ||
| Q2 25 | 0.95× | 2.41× | ||
| Q1 25 | 6.72× | — | ||
| Q4 24 | 2.82× | — | ||
| Q3 24 | 0.87× | — | ||
| Q2 24 | 1.71× | 5.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESP
暂无分部数据
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
